In vitro availability of iron from cereal meal with the addition of protein isolates and fenugreek leaves (Trigonella foenum-graecum)

In vitro iron availability was determined from a standard cereal meal (C) with and without the addition of protein isolates from bovine milk (BP), groundnut milk (GP) and soybean milk (SP). A second set of studies were done to investigate the potentially available iron from fenugreek leaves per se and the effect of their addition on the available iron from the cereal meal. The potentially available iron from the meal increased from 4.91% to 6.73% on the addition of BP. The next best enhancer was GP (4.91% to 6.17%). Although the addition of SP increased the total iron content of the cereal meal significantly, the percent available iron decreased compared to the other milk proteins. The addition of fenugreek leaves (100 g/meal) to the meal increased the total iron content of the meal significantly (3.24 mg to 9.12 mg) (p<.001), however, the available iron was observed to decrease (4.91% vs 4.34%).     

A novel MCT1 and MCT4 dual inhibitor reduces mitochondrial metabolism and inhibits tumour growth of feline oral squamous cell carcinoma

Monocarboxylate transporters (MCTs) support tumour growth by regulating the transport of metabolites in the tumour microenvironment. High MCT1 or MCT4 expression is correlated with poor outcomes in human patients with head and neck squamous cell carcinoma (HNSCC). Recently, drugs targeting these transporters have been developed and may prove to be an effective treatment strategy for HNSCC. Feline oral squamous cell carcinoma (OSCC) is an aggressive and treatment‐resistant malignancy resembling advanced or recurrent HNSCC. The goals of this study were to investigate the effects of a previously characterized dual MCT1 and MCT4 inhibitor, MD‐1, in OSCC as a novel treatment approach for feline oral cancer. We also sought to determine the potential of feline OSCC as a large animal model for the further development of MCT inhibitors to treat human HNSCC. In vitro, MD‐1 reduced the viability of feline OSCC and human HNSCC cell lines, altered glycolytic and mitochondrial metabolism and synergized with platinum‐based chemotherapies. While MD‐1 treatment increased lactate concentrations in an HNSCC cell line, the inhibitor failed to alter lactate levels in feline OSCC cells, suggesting an MCT‐independent activity. In vivo, MD‐1 significantly inhibited tumour growth in a subcutaneous xenograft model and prolonged overall survival in an orthotopic model of feline OSCC. Our results show that MD‐1 may be an effective therapy for the treatment of feline oral cancer. Our findings also support the further investigation of feline OSCC as a large animal model to inform the development of MCT inhibitors and future clinical studies in human HNSCC.     

In vitro antimicrobial activity of equine platelet lysate and mesenchymal stromal cells against common clinical pathogens

Septic arthritis is considered a medical emergency. Disease following bacterial colonization can lead to significant morbidity and mortality and requires costly treatment. Antimicrobial properties of regenerative therapies, including mesenchymal stromal cells and platelet products, have been researched extensively in human medicine. Although fewer studies have been conducted in veterinary species, they have shown promising results. The purpose of this study was to evaluate bacterial suppression by equine platelet lysate (EPL) and adipose-derived mesenchymal stromal cells (ASCs) in vitro. We hypothesized that both products would significantly inhibit the growth of Staphylococcus aureus and Escherichia coli. Pooled blood from 10 horses was used for production of EPL. Mesenchymal stromal cells were isolated from adipose tissue harvested from the gluteal region of 3 horses. The study evaluated 3 treatment groups: 10 × EPL, 1.6 million ASCs, and a control, using an incomplete unbalanced block design with repeated measurements. Optical density readings and colony-forming units/mL were calculated at 0, 3, 6, 9, 12, 18, and 24 hours. Decreased bacterial growth was seen at multiple time points for the S. aureus-ASC and S. aureus-EPL treatments, supporting our hypothesis. Increased bacterial growth was noticed in the E. coli-EPL group, with no difference in the E. coli-ASC treatment, which opposed our hypothesis. A clear conclusion of antimicrobial effects of EPL and ASCs cannot be made from this in vitro study. Although it appears that ASCs have a significant effect on decreasing the growth of S. aureus, further studies are needed to explore these effects, particularly in Gram-positive bacteria.     

Heavy-Metal Concentrations in Sediments Collected from ICRISAT Lake,Patancheru, India

To determine and characterize the initial background concentrations of heavy metals, a total of 50 sediment samples were collected from the largest lake at the International Crops Research Institute for the Semi-arid Tropics (ICRISAT) in Patancheru, India. The finely ground sediment samples were digested using a microwave-assisted digestion method and analyzed for 15 heavy metals using inductively coupled plasma–optical emission spectrometry (ICP-OES). The results showed that the concentrations of the heavy metals varied greatly with metal and sediment sample, but in general the concentrations were low. Our results suggest that the sediments from this lake (15 ha in area) at the ICRISAT center do not appear contaminated with the heavy metals evaluated, and they indeed reflect normal background concentrations of these metals released through the natural process of weathering.